News

David Johnson will remain CEO of ConvaTec, supported by the current ConvaTec management team. As previously announced, Nordic Capital and Avista Capital Partners plan to integrate Unomedical, a

Mr Smilek replaces former CFO Mariam Morris, who resigned effective August 1, 2008 and will serve as a part-time consultant to the company to assist in the management

Pozen plans to meet with the FDA to discuss its responses to the company’s proposed protocol for the Phase III pivotal studies, including the inclusion/exclusion criteria, the stratification

The assets acquired include intellectual property, product inventory and clinical data as well as all technologies related to the CellSearch system, claimed to be the first diagnostic test

Mr Carr joins Arca from Anesiva, where he served as vice president of marketing for pain management products since 2004. In this role, he was responsible for leading

Under the terms of the agreement, Meda will pay $392 million in cash for the Valeant subsidiaries in those markets, and the rights to all products and licenses

Astellas’s European subsidiary has submitted a marketing authorization application under the centralized procedure to European Medicines Agency for Mycamine in April 2006. Following the review, the European Committee

Tracleer is claimed to be the first pulmonary arterial hypertension (PAH) treatment ever to be investigated in a clinical study that exclusively enrolled patients with mildly symptomatic pulmonary

Mr Watson has over 25 years experience in general management, operations, business development and sales. Prior to joining Girindus, Mr Watson was senior director of North American sales